STAAR Surgical Company Profile Avatar - Palmy Investing

STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collame…
Medical - Instruments & Supplies
US, Lake Forest [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
1.00 -4.00 5.00 3.00 3.00 -7.00 -2.00 1.00 2.00 12.00 25.00 20.00 43.00 35.00 14.00
Operating Cash (Net)
1.00 -4.00 5.00 3.00 3.00 -7.00 -2.00 1.00 2.00 12.00 25.00 20.00 43.00 35.00 14.00
Accounts Receivable
- - - - - - - - -2.00 - - -4.00 - - -1.00 -6.00 -4.00 -3.00 -8.00 -19.00 -32.00
Accounts Payable
1.00 -1.00 - - 1.00 - - - - - - 1.00 -2.00 - - 1.00 - - - - 1.00 - -
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-7.00 18.00 - - -2.00 -3.00 -4.00 -2.00 -3.00 -1.00 -2.00 -10.00 -8.00 -13.00 -156.00 74.00
Capital Expenditure
- - - - - - -2.00 -3.00 -4.00 -2.00 -3.00 -1.00 -2.00 -10.00 -8.00 -13.00 -18.00 -18.00
Purchases of Investments
- - - - - - - - - - - - - - - - - - - - - - - - - - -155.00 -52.00
Sale/Maturity of Investment
- - - - - - - - - - - - - - - - - - - - - - - - - - 17.00 144.00
Property, Plant, Equipment (P&PE)
- - - - - - -2.00 -3.00 -4.00 -2.00 -3.00 -1.00 -2.00 -10.00 -8.00 -13.00 -18.00 -18.00
Acquisitions (Net)
- - 11.00 - - - - - - - - - - - - - - - - - - - - - - 138.00 - -
Other Investing Activities
-7.00 7.00 - - - - - - - - - - - - - - - - - - - - - - -138.00 - -
Financing Activities
Used Cash (Net)
-7.00 -11.00 -2.00 -4.00 -2.00 -2.00 -4.00 -2.00 -2.00 -74.00 - - -19.00 -17.00 -8.00 -7.00
Debt Repayment
-1.00 -5.00 - - - - - - - - - - - - -1.00 -2.00 -1.00 - - -1.00 - - - -
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
- - 6 - - - - - - - - - - - - - - 72 - - - - - - - - 11
Other Financing Activities
- - 1.00 3.00 5.00 3.00 3.00 4.00 7.00 7.00 10.00 1.00 20.00 19.00 8.00 - -
Cash Balances
Begin of Period
4.00 6.00 9.00 16.00 21.00 22.00 13.00 13.00 14.00 18.00 103.00 119.00 152.00 199.00 86.00
End of Period
6.00 9.00 16.00 21.00 22.00 13.00 13.00 13.00 18.00 103.00 119.00 152.00 199.00 86.00 183.00
Change
1.00 3.00 7.00 5.00 1.00 -9.00 - - - - 4.00 85.00 15.00 32.00 47.00 -113.00 96.00
Non-Cash Balances
Depreciation and Amortization
3.00 2.00 2.00 1.00 2.00 2.00 2.00 2.00 3.00 2.00 3.00 3.00 3.00 4.00 5.00
Stock Based Compensation
1.00 1.00 1.00 3.00 4.00 4.00 3.00 8.00 3.00 - - 10.00 12.00 14.00 20.00 23.00
Other
- - - - - - - - - - - - - - - - 3.00 2.00 2.00 3.00 2.00 2.00 2.00
Highlighted metrics
Free Cash Flow (FCF)
- - -4.00 4.00 - - - - -12.00 -4.00 -2.00 1.00 10.00 15.00 12.00 30.00 17.00 -3.00
Cash Conversion Cycle (CCC)
125.00 179.00 172.00 171.00 157.00 180.00 212.00 171.00 172.00 190.00 162.00 161.00 129.00 155.00 223.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of STAA's Analysis
CIK: 718937 CUSIP: 852312305 ISIN: US8523123052 LEI: - UEI: -
Secondary Listings
STAA has no secondary listings inside our databases.